SCHEMBL30656015

SCHEMBL30656015

Cc1sc2ccc(OCc3cccnc3C(F)(F)F)cc2c1C(=O)NC1(CO)CCOCC1

nearest known ligand 0.39

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ADAM17 P78536 3/20 0.39
MMP3 P08254 2/20 0.39
MMP7 P09237 2/20 0.39
ADAMTS4 O75173 1/20 0.39
ADAMTS1 Q9UHI8 1/20 0.39
ADAMTS5 Q9UNA0 1/20 0.39
CD274 Q9NZQ7 1/20 0.37
BTK Q06187 1/20 0.37
MMP2 P08253 1/20 0.36
MMP12 P39900 1/20 0.36
MMP13 P45452 1/20 0.36
CNR2 P34972 2/20 0.36
DGAT2 Q96PD7 3/20 0.35
ANO1 Q5XXA6 5/20 0.34
CNR1 P21554 1/20 0.32
SCN9A Q15858 1/20 0.32
CD38 P28907 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30656066 0.95 SCN9A (0.35) ADAM17MMP3MMP7ADAMTS4ADAMTS1
SCHEMBL30656274 0.89 ADAM17 (0.41) ADAM17MMP3MMP7ADAMTS4ADAMTS1
SCHEMBL30656046 0.88 CD274 (0.41) ADAM17MMP3MMP7ADAMTS4ADAMTS1
SCHEMBL30656068 0.86 MMP13 (0.42) ADAM17MMP3MMP7ADAMTS4ADAMTS1
SCHEMBL24484887 0.85 SLC26A4 (0.45) ADAM17MMP3MMP7ADAMTS4ADAMTS1
SCHEMBL30656223 0.84 BTK (0.42) ADAM17MMP3MMP7ADAMTS4ADAMTS1
SCHEMBL30656331 0.83 ALDH1A1 (0.38) CD38
SCHEMBL30656076 0.83 ALDH1A1 (0.42)
SCHEMBL30656232 0.82 KDM4E (0.43) ADAM17MMP3MMP7ADAMTS4ADAMTS1
SCHEMBL24484976 0.82 SLC26A4 (0.45) ADAM17MMP3MMP7ADAMTS4ADAMTS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4532013-A1 NEW DERIVATIVES FOR TREATING TRPM3 MEDIATED DISORDERS Katholieke Universiteit Leuven KU Leuven Research & Development (BE) 2025-04-09 EP claimed
WO-2023227697-A1 NEW DERIVATIVES FOR TREATING TRPM3 MEDIATED DISORDERS KATHOLIEKE UNIVERSITEIT LEUVEN (BE) 2023-11-30 WO claimed
EP-4532013-A1 NEW DERIVATIVES FOR TREATING TRPM3 MEDIATED DISORDERS Katholieke Universiteit Leuven KU Leuven Research & Development (BE) 2025-04-09 EP disclosed
WO-2023227697-A1 NEW DERIVATIVES FOR TREATING TRPM3 MEDIATED DISORDERS KATHOLIEKE UNIVERSITEIT LEUVEN (BE) 2023-11-30 WO disclosed